XML 44 R29.htm IDEA: XBRL DOCUMENT v3.20.2
STOCK-BASED COMPENSATION PLAN (Tables)
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Summary of the nonvested restricted stock awards outstanding and the assumptions used to estimate the fair value of the awards
The following table summarizes the nonvested restricted stock awards outstanding for SJI at June 30, 2020 and the assumptions used to estimate the fair value of the awards:

 GrantsShares OutstandingFair Value Per ShareExpected VolatilityRisk-Free Interest Rate
Officers & Key Employees -2018 - TSR48,304  $31.05  21.9 %2.00 %
2018 - CEGR, Time63,389  $31.23  N/AN/A
2019 - TSR36,642  $32.88  23.2 %2.40 %
2019 - CEGR, Time101,982  $31.38  N/AN/A
2020 - TSR119,827  $25.51  34.8 %0.21 %
2020 - Time105,451  $25.19  N/AN/A
Directors -202036,829  $32.42  N/AN/A
 
Summary of the total stock-based compensation cost for the period
The following table summarizes the total stock-based compensation cost to SJI for the three and six months ended June 30, 2020 and 2019 (in thousands):

 Three Months Ended
June 30,
Six Months Ended
June 30,
 2020201920202019
Officers & Key Employees$1,239  $1,534  $2,451  $2,284  
Directors298  202  597  404  
Total Cost1,537  1,736  3,048  2,688  
Capitalized99  47  (23) (34) 
Net Expense$1,636  $1,783  $3,025  $2,654  
Summary of information regarding restricted stock award activity during the period excluding accrued dividend equivalents
The following table summarizes information regarding restricted stock award activity for SJI during the six months ended June 30, 2020, excluding accrued dividend equivalents:

 Officers and Other Key EmployeesDirectorsWeighted
Average
Fair Value
Nonvested Shares Outstanding, January 1, 2020402,146  30,961  $31.50  
  Granted225,278  36,829  $26.42  
  Cancelled/Forfeited(14,867) —  $31.48  
  Vested*(136,963) (30,961) $31.49  
Nonvested Shares Outstanding, June 30, 2020
475,594  36,829  $28.90  
*Earnings and performance-based targets during the three-year vesting periods were not attained for the 2017 Officer and other key employee grants that vested in the first quarter of 2020. As a result, no shares were awarded in 2020 associated with the 2017 TSR and CEGR-based grants.